Background: Among patients with end-stage kidney disease (ESKD), arterial stiffness is
considered as a powerful predictor of cardiovascular (CV) morbidity and mortality. However …

Objective: Previous studies have suggested that blood pressure variability (BPV) is
associated with an increased risk of mortality and cardiovascular events in patients on …

Rationale & Objective Observational studies have reported a U-shaped association between
blood pressure (BP) before a hemodialysis session and death. In contrast, because a linear …

Background: Angiotensin converting enzyme inhibitors (ACEi) and angiotensin receptor
blockers (ARB) are increasingly used in uremic patients (pts). However, their effect on serum …

Blood pressure (BP) is reportedly a predictor of mortality in hemodialysis (HD) patients;
however, it is unclear whether pre-or postdialysis BP has greater predictive power. To …

Hypertension is extremely common in patients with end-stage renal disease who are
receiving hemodialysis, and cardiovascular disease remains the leading cause of death in …

Background The natural history of patients commencing dialysis in East Yorkshire is not well
characterised and there is little convincing evidence which has studied the impact of …

Chronic kidney disease (CKD) is a public health priority. The unadjusted mortality rate of
end-stage renal disease (ESRD) is 29% at 2 years and 52% at 5 years. ESRD is associated …

Introduction: Patients with end‐stage renal disease (ESRD) have reduced endothelial
function, but whether macro‐and microvascular endothelial function correlate with baseline …

Background The current literature recognises that left ventricular hypertrophy makes a key
contribution to the high rate of premature cardiovascular mortality in dialysis patients …